

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.12036896 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.12036896 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.08204932 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.92517711 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.92517711 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.92517711 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.92517711 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.92517711 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.92517711 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.55717191 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55615071 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.40733894 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 5.35563629 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.35563629 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 5.34262238 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.34262238 |
| 17 | detection of other organism (GO:0098543) | 5.23852586 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.23378534 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 5.15297269 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05640262 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.01365391 |
| 22 | detection of bacterium (GO:0016045) | 5.00214377 |
| 23 | response to peptidoglycan (GO:0032494) | 4.98074565 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.96000272 |
| 25 | cysteine metabolic process (GO:0006534) | 4.89666471 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.83248091 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 4.78585827 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 4.64338442 |
| 29 | detection of external biotic stimulus (GO:0098581) | 4.62402712 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.50884504 |
| 31 | urea cycle (GO:0000050) | 4.48953260 |
| 32 | urea metabolic process (GO:0019627) | 4.48953260 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40192296 |
| 34 | glyoxylate metabolic process (GO:0046487) | 4.37965727 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.36630779 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.33275309 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 4.33086532 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 4.32456888 |
| 39 | bile acid biosynthetic process (GO:0006699) | 4.29834935 |
| 40 | tryptophan catabolic process (GO:0006569) | 4.29319595 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 4.29319595 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 4.29319595 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29005110 |
| 44 | protein carboxylation (GO:0018214) | 4.29005110 |
| 45 | leukocyte aggregation (GO:0070486) | 4.28610509 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.27876643 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.27150188 |
| 48 | low-density lipoprotein particle clearance (GO:0034383) | 4.26133940 |
| 49 | cellular extravasation (GO:0045123) | 4.24945124 |
| 50 | lysine catabolic process (GO:0006554) | 4.15323187 |
| 51 | lysine metabolic process (GO:0006553) | 4.15323187 |
| 52 | respiratory burst (GO:0045730) | 4.11742232 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 4.11667162 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.10505640 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 4.09764003 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09453411 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.09247512 |
| 58 | regulation of protein activation cascade (GO:2000257) | 4.08708183 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 4.07320730 |
| 60 | homocysteine metabolic process (GO:0050667) | 4.06133477 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.05774689 |
| 62 | tryptophan metabolic process (GO:0006568) | 4.04468538 |
| 63 | response to host immune response (GO:0052572) | 4.03495969 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.03495969 |
| 65 | detection of biotic stimulus (GO:0009595) | 4.02899202 |
| 66 | neutrophil activation (GO:0042119) | 4.00186738 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98612097 |
| 68 | amino-acid betaine metabolic process (GO:0006577) | 3.96595345 |
| 69 | glycine metabolic process (GO:0006544) | 3.89719351 |
| 70 | regulation of complement activation (GO:0030449) | 3.89158833 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 3.83827281 |
| 72 | regulation of fibrinolysis (GO:0051917) | 3.80579208 |
| 73 | reverse cholesterol transport (GO:0043691) | 3.80290001 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78724224 |
| 75 | response to host (GO:0075136) | 3.78724224 |
| 76 | response to host defenses (GO:0052200) | 3.78724224 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.77313362 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.77245236 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74377841 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.74334416 |
| 81 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.73307019 |
| 82 | bile acid metabolic process (GO:0008206) | 3.72529354 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.71661176 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 3.71661176 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70388492 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 3.70388492 |
| 87 | macromolecular complex remodeling (GO:0034367) | 3.70388492 |
| 88 | cellular response to type I interferon (GO:0071357) | 3.70178022 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.70178022 |
| 90 | granulocyte activation (GO:0036230) | 3.69404834 |
| 91 | response to type I interferon (GO:0034340) | 3.67451406 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66085720 |
| 93 | response to interleukin-15 (GO:0070672) | 3.65787963 |
| 94 | valine metabolic process (GO:0006573) | 3.64204789 |
| 95 | microglial cell activation (GO:0001774) | 3.61172246 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.58835893 |
| 97 | ethanol oxidation (GO:0006069) | 3.58359479 |
| 98 | acylglycerol homeostasis (GO:0055090) | 3.57315793 |
| 99 | triglyceride homeostasis (GO:0070328) | 3.57315793 |
| 100 | phospholipid efflux (GO:0033700) | 3.55378651 |
| 101 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.55167017 |
| 102 | macrophage activation (GO:0042116) | 3.55131893 |
| 103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.53095647 |
| 104 | regulation of cholesterol esterification (GO:0010872) | 3.52081255 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51637202 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.49969457 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 3.49014483 |
| 108 | alpha-amino acid catabolic process (GO:1901606) | 3.48227455 |
| 109 | aromatic amino acid family metabolic process (GO:0009072) | 3.47650742 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 3.44540205 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43436046 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.41755910 |
| 113 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38701788 |
| 114 | response to muramyl dipeptide (GO:0032495) | 3.37625476 |
| 115 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36423620 |
| 116 | regulation of cholesterol storage (GO:0010885) | 3.36173350 |
| 117 | cellular modified amino acid catabolic process (GO:0042219) | 3.34898074 |
| 118 | phospholipid homeostasis (GO:0055091) | 3.34728622 |
| 119 | B cell receptor signaling pathway (GO:0050853) | 3.32943148 |
| 120 | neutrophil mediated immunity (GO:0002446) | 3.32910779 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.32503012 |
| 122 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.32111149 |
| 123 | cellular amino acid catabolic process (GO:0009063) | 3.29799141 |
| 124 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29423751 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27971069 |
| 126 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27971069 |
| 127 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.27835839 |
| 128 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.27466844 |
| 129 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.27466844 |
| 130 | fatty acid beta-oxidation (GO:0006635) | 3.26559781 |
| 131 | aldehyde catabolic process (GO:0046185) | 3.25989781 |
| 132 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.24900390 |
| 133 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24530277 |
| 134 | imidazole-containing compound metabolic process (GO:0052803) | 3.22787925 |
| 135 | fatty acid oxidation (GO:0019395) | 3.22289881 |
| 136 | 2-oxoglutarate metabolic process (GO:0006103) | 3.21480242 |
| 137 | germinal center formation (GO:0002467) | 3.20929015 |
| 138 | tyrosine metabolic process (GO:0006570) | 3.20880432 |
| 139 | protein-lipid complex assembly (GO:0065005) | 3.20702257 |
| 140 | cellular response to interleukin-15 (GO:0071350) | 3.20652299 |
| 141 | fibrinolysis (GO:0042730) | 3.18913952 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18372328 |
| 143 | lipid oxidation (GO:0034440) | 3.17896147 |
| 144 | bile acid and bile salt transport (GO:0015721) | 3.17269774 |
| 145 | cholesterol homeostasis (GO:0042632) | 3.16646516 |
| 146 | cholesterol efflux (GO:0033344) | 3.16218844 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 3.15960203 |
| 148 | sterol homeostasis (GO:0055092) | 3.14014231 |
| 149 | positive regulation of mast cell activation (GO:0033005) | 3.12751156 |
| 150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12701720 |
| 151 | carnitine metabolic process (GO:0009437) | 3.12282563 |
| 152 | regulation of tolerance induction (GO:0002643) | 3.11447846 |
| 153 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.11115064 |
| 154 | L-serine metabolic process (GO:0006563) | 3.10833891 |
| 155 | lipoprotein metabolic process (GO:0042157) | 3.10536322 |
| 156 | benzene-containing compound metabolic process (GO:0042537) | 3.08661623 |
| 157 | cellular glucuronidation (GO:0052695) | 3.08640461 |
| 158 | pentose-phosphate shunt (GO:0006098) | 3.07981588 |
| 159 | plasma lipoprotein particle organization (GO:0071827) | 3.07635495 |
| 160 | defense response to protozoan (GO:0042832) | 3.07625264 |
| 161 | negative regulation of phagocytosis (GO:0050765) | 3.07603525 |
| 162 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06821852 |
| 163 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06699924 |
| 164 | cellular ketone body metabolic process (GO:0046950) | 3.06379391 |
| 165 | urate metabolic process (GO:0046415) | 3.05616520 |
| 166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05183452 |
| 167 | NADPH regeneration (GO:0006740) | 3.04004627 |
| 168 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03532935 |
| 169 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02066915 |
| 170 | ethanol metabolic process (GO:0006067) | 3.01345410 |
| 171 | regulation of mast cell activation (GO:0033003) | 3.01037127 |
| 172 | regulation of B cell differentiation (GO:0045577) | 3.00936518 |
| 173 | carboxylic acid catabolic process (GO:0046395) | 3.00915389 |
| 174 | organic acid catabolic process (GO:0016054) | 3.00915389 |
| 175 | glutamate metabolic process (GO:0006536) | 3.00646012 |
| 176 | fatty acid catabolic process (GO:0009062) | 3.00280118 |
| 177 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00190273 |
| 178 | response to nitrosative stress (GO:0051409) | 2.99165565 |
| 179 | positive regulation of B cell differentiation (GO:0045579) | 2.97324039 |
| 180 | positive regulation of interferon-alpha production (GO:0032727) | 2.97129343 |
| 181 | B cell mediated immunity (GO:0019724) | 2.95923794 |
| 182 | regulation of regulated secretory pathway (GO:1903305) | 2.95654689 |
| 183 | negative regulation of innate immune response (GO:0045824) | 2.95385321 |
| 184 | leukocyte degranulation (GO:0043299) | 2.88896866 |
| 185 | negative regulation of type 2 immune response (GO:0002829) | 2.88873742 |
| 186 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.88185306 |
| 187 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86806591 |
| 188 | positive thymic T cell selection (GO:0045059) | 2.85585737 |
| 189 | negative regulation of interleukin-6 production (GO:0032715) | 2.84496328 |
| 190 | myeloid leukocyte mediated immunity (GO:0002444) | 2.83745116 |
| 191 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81989744 |
| 192 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81396934 |
| 193 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79939915 |
| 194 | dendritic cell chemotaxis (GO:0002407) | 2.78965365 |
| 195 | regulation of interferon-alpha production (GO:0032647) | 2.76255232 |
| 196 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75791187 |
| 197 | positive regulation of mast cell degranulation (GO:0043306) | 2.75791187 |
| 198 | dendritic cell migration (GO:0036336) | 2.72493694 |
| 199 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71876319 |
| 200 | response to protozoan (GO:0001562) | 2.71314874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.86272845 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.55179119 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.37364475 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.07523755 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.28524740 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.01099191 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44640622 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.18740384 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.73480645 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70656769 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.56049646 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.41495324 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40554492 |
| 14 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.31743650 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28313593 |
| 16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.27517611 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11191120 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05830740 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02352072 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00602750 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99417303 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97686026 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97663885 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97373528 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95743036 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95475578 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89431789 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84341815 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.82423856 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79242506 |
| 31 | * MAF_26560356_Chip-Seq_TH2_Human | 1.78885424 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77234506 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69815168 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69428508 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69346687 |
| 36 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68272617 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63893016 |
| 38 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62392915 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60156218 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59770903 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56801863 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55576754 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54720335 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54141621 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.52454294 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50873268 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48703247 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38847019 |
| 49 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38524118 |
| 50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36779042 |
| 51 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35601011 |
| 52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35214148 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35172736 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34048841 |
| 55 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32481956 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31223831 |
| 57 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30056859 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29215595 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28407466 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24526912 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22534945 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21860095 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21419458 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20699815 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20476324 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20460869 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20077366 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19469870 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19006634 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18801168 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17662303 |
| 72 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16985956 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14709054 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.14575682 |
| 75 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14172309 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13684818 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13614996 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13346391 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11853407 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11051500 |
| 81 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.10271403 |
| 82 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.10190592 |
| 83 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10012509 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07677401 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07072521 |
| 86 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06675717 |
| 87 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05714408 |
| 88 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05389246 |
| 89 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03953883 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03847004 |
| 91 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03819028 |
| 92 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03363837 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02827080 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02664506 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97486415 |
| 96 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96896807 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96625370 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95485227 |
| 99 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95109307 |
| 100 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94533433 |
| 101 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94254316 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93963059 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93718091 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93284232 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93029090 |
| 106 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92419720 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91203734 |
| 108 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90351023 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90155048 |
| 110 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89674418 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87251783 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86518291 |
| 113 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84499177 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83436329 |
| 115 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83420955 |
| 116 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83405653 |
| 117 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83230192 |
| 118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82721646 |
| 119 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82175082 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82044778 |
| 121 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81550032 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81299228 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81196722 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81128236 |
| 125 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79787087 |
| 126 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79663153 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79271087 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78561888 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78244015 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78206747 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78001262 |
| 132 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77457233 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76506199 |
| 134 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.75475318 |
| 135 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75209205 |
| 136 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.75109335 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75023539 |
| 138 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.74659693 |
| 139 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74242934 |
| 140 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.73772419 |
| 141 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.73607150 |
| 142 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72764545 |
| 143 | MYB_26560356_Chip-Seq_TH1_Human | 0.71793172 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71770056 |
| 145 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.71696702 |
| 146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71380246 |
| 147 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.71165294 |
| 148 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.70198578 |
| 149 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68714826 |
| 150 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68685034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.78946783 |
| 2 | MP0005360_urolithiasis | 5.62002880 |
| 3 | MP0005365_abnormal_bile_salt | 4.35705888 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.10649594 |
| 5 | MP0009840_abnormal_foam_cell | 3.55230058 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.51271037 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.30887829 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.88213963 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.61417412 |
| 10 | MP0003252_abnormal_bile_duct | 2.57269352 |
| 11 | MP0005671_abnormal_response_to | 2.49912451 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.47843946 |
| 13 | MP0002723_abnormal_immune_serum | 2.41345091 |
| 14 | MP0008260_abnormal_autophagy | 2.38062915 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.36234787 |
| 16 | MP0001819_abnormal_immune_cell | 2.34299590 |
| 17 | MP0005083_abnormal_biliary_tract | 2.31527766 |
| 18 | MP0005332_abnormal_amino_acid | 2.24144630 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.14898567 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.10303514 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.03960055 |
| 22 | MP0000609_abnormal_liver_physiology | 2.02576032 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.91018366 |
| 24 | MP0003436_decreased_susceptibility_to | 1.86291358 |
| 25 | MP0003195_calcinosis | 1.81971906 |
| 26 | MP0003828_pulmonary_edema | 1.80597175 |
| 27 | MP0002398_abnormal_bone_marrow | 1.80259824 |
| 28 | MP0003186_abnormal_redox_activity | 1.77847899 |
| 29 | MP0002132_abnormal_respiratory_system | 1.77117053 |
| 30 | MP0000716_abnormal_immune_system | 1.76652560 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.75892358 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.75810665 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.73420139 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.69384140 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.63966085 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.62644078 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.60546143 |
| 38 | MP0005670_abnormal_white_adipose | 1.51845632 |
| 39 | MP0002722_abnormal_immune_system | 1.48632622 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.45540274 |
| 41 | MP0003866_abnormal_defecation | 1.43475923 |
| 42 | MP0002429_abnormal_blood_cell | 1.43394319 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.40977547 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.39512918 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.39442779 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.36363441 |
| 47 | MP0003303_peritoneal_inflammation | 1.35381756 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33258811 |
| 49 | MP0004883_abnormal_blood_vessel | 1.33048526 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.30981844 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.29688701 |
| 52 | MP0002254_reproductive_system_inflammat | 1.29567049 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.29556309 |
| 54 | MP0003724_increased_susceptibility_to | 1.29550654 |
| 55 | MP0004510_myositis | 1.29398404 |
| 56 | MP0000604_amyloidosis | 1.28418302 |
| 57 | MP0001764_abnormal_homeostasis | 1.28335762 |
| 58 | MP0009764_decreased_sensitivity_to | 1.25723850 |
| 59 | MP0005310_abnormal_salivary_gland | 1.25443859 |
| 60 | MP0000598_abnormal_liver_morphology | 1.24431708 |
| 61 | MP0004381_abnormal_hair_follicle | 1.23752758 |
| 62 | MP0008469_abnormal_protein_level | 1.21254134 |
| 63 | MP0009785_altered_susceptibility_to | 1.19631845 |
| 64 | MP0001851_eye_inflammation | 1.18367734 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.18220330 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.17998871 |
| 67 | MP0005023_abnormal_wound_healing | 1.14940386 |
| 68 | MP0001853_heart_inflammation | 1.13638549 |
| 69 | MP0009763_increased_sensitivity_to | 1.13113595 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.12487182 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.12029719 |
| 72 | MP0005451_abnormal_body_composition | 1.12019671 |
| 73 | MP0002419_abnormal_innate_immunity | 1.11286428 |
| 74 | MP0004858_abnormal_nervous_system | 1.07789185 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.06838992 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.04124194 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.04080434 |
| 78 | MP0004130_abnormal_muscle_cell | 1.00630046 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.00148927 |
| 80 | MP0004185_abnormal_adipocyte_glucose | 0.99929985 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.99702933 |
| 82 | MP0003448_altered_tumor_morphology | 0.98841248 |
| 83 | MP0000685_abnormal_immune_system | 0.98586394 |
| 84 | MP0004947_skin_inflammation | 0.97823275 |
| 85 | MP0005025_abnormal_response_to | 0.97461289 |
| 86 | MP0000490_abnormal_crypts_of | 0.94629289 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.93133284 |
| 88 | MP0002971_abnormal_brown_adipose | 0.93069921 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.92491721 |
| 90 | MP0005390_skeleton_phenotype | 0.91979437 |
| 91 | MP0003075_altered_response_to | 0.89566700 |
| 92 | MP0008004_abnormal_stomach_pH | 0.87725089 |
| 93 | MP0001835_abnormal_antigen_presentation | 0.87416549 |
| 94 | MP0000343_altered_response_to | 0.87125552 |
| 95 | MP0001663_abnormal_digestive_system | 0.87018417 |
| 96 | MP0006082_CNS_inflammation | 0.86677362 |
| 97 | MP0003868_abnormal_feces_composition | 0.86605343 |
| 98 | MP0003011_delayed_dark_adaptation | 0.84969292 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.84958215 |
| 100 | MP0009278_abnormal_bone_marrow | 0.84862866 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.83821650 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.81863412 |
| 103 | MP0003091_abnormal_cell_migration | 0.81571157 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.79371662 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.79371662 |
| 106 | MP0001756_abnormal_urination | 0.78009484 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.77863748 |
| 108 | MP0001873_stomach_inflammation | 0.77450148 |
| 109 | MP0001661_extended_life_span | 0.76959444 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.75986387 |
| 111 | MP0000858_altered_metastatic_potential | 0.75584566 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.74441531 |
| 113 | MP0001881_abnormal_mammary_gland | 0.74413381 |
| 114 | MP0003690_abnormal_glial_cell | 0.73116338 |
| 115 | MP0005334_abnormal_fat_pad | 0.72458732 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.71758045 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.70698909 |
| 118 | MP0005647_abnormal_sex_gland | 0.70391599 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.69833388 |
| 120 | MP0005275_abnormal_skin_tensile | 0.69792579 |
| 121 | MP0000249_abnormal_blood_vessel | 0.69073271 |
| 122 | MP0002060_abnormal_skin_morphology | 0.68907205 |
| 123 | MP0005164_abnormal_response_to | 0.68727976 |
| 124 | MP0003795_abnormal_bone_structure | 0.68671916 |
| 125 | MP0005166_decreased_susceptibility_to | 0.68521583 |
| 126 | MP0009115_abnormal_fat_cell | 0.68387290 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67200790 |
| 128 | MP0008874_decreased_physiological_sensi | 0.66449281 |
| 129 | MP0005000_abnormal_immune_tolerance | 0.65737128 |
| 130 | MP0001958_emphysema | 0.65537176 |
| 131 | MP0003045_fibrosis | 0.65513369 |
| 132 | MP0009053_abnormal_anal_canal | 0.65055218 |
| 133 | MP0005387_immune_system_phenotype | 0.63974439 |
| 134 | MP0001790_abnormal_immune_system | 0.63974439 |
| 135 | MP0002796_impaired_skin_barrier | 0.63790197 |
| 136 | MP0008873_increased_physiological_sensi | 0.63741993 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.63598991 |
| 138 | MP0001800_abnormal_humoral_immune | 0.63079196 |
| 139 | MP0002933_joint_inflammation | 0.62288547 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.62141856 |
| 141 | MP0002452_abnormal_antigen_presenting | 0.61070106 |
| 142 | MP0001849_ear_inflammation | 0.60705888 |
| 143 | MP0003329_amyloid_beta_deposits | 0.60246158 |
| 144 | MP0002405_respiratory_system_inflammati | 0.60105390 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.59854563 |
| 146 | MP0001243_abnormal_dermal_layer | 0.59287494 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.58853137 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.58159874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.78182091 |
| 2 | Myositis (HP:0100614) | 5.39350110 |
| 3 | Xanthomatosis (HP:0000991) | 5.33981720 |
| 4 | Orchitis (HP:0100796) | 5.20141830 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.18731666 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.15825663 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.14467709 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.74060961 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.73702703 |
| 10 | Optic neuritis (HP:0100653) | 4.73702703 |
| 11 | Complement deficiency (HP:0004431) | 4.56555850 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.33533789 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.16194768 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.06270969 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05950630 |
| 16 | Obstructive lung disease (HP:0006536) | 4.05950630 |
| 17 | Hyperammonemia (HP:0001987) | 4.00237191 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99083185 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.98255246 |
| 20 | Hyperglycinuria (HP:0003108) | 3.95050842 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.84702668 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.84469414 |
| 23 | Stomatitis (HP:0010280) | 3.84451565 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.80983760 |
| 25 | Meningitis (HP:0001287) | 3.80078371 |
| 26 | Abnormality of complement system (HP:0005339) | 3.76033985 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.72615058 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72615058 |
| 29 | Gingivitis (HP:0000230) | 3.71140659 |
| 30 | Recurrent skin infections (HP:0001581) | 3.70625835 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65518489 |
| 32 | Hyperglycinemia (HP:0002154) | 3.62120871 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.60305704 |
| 34 | Joint hemorrhage (HP:0005261) | 3.56637471 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.54955378 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53525174 |
| 37 | Cellulitis (HP:0100658) | 3.53327819 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.50034686 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49917520 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.48714421 |
| 41 | Myocardial infarction (HP:0001658) | 3.47581277 |
| 42 | Increased IgE level (HP:0003212) | 3.45953943 |
| 43 | Epidermoid cyst (HP:0200040) | 3.43717878 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.40918467 |
| 45 | Encephalitis (HP:0002383) | 3.30402032 |
| 46 | Ketosis (HP:0001946) | 3.29915224 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 3.28336444 |
| 48 | Vasculitis (HP:0002633) | 3.25878559 |
| 49 | Hypoglycemic coma (HP:0001325) | 3.24434273 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19009127 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16688897 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16688897 |
| 53 | Keratoconjunctivitis (HP:0001096) | 3.12630397 |
| 54 | Fat malabsorption (HP:0002630) | 3.12257221 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.12245719 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09030369 |
| 57 | Hypercholesterolemia (HP:0003124) | 3.01602147 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 3.00629599 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.98812203 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.97250552 |
| 61 | Hypochromic anemia (HP:0001931) | 2.89444249 |
| 62 | Abnormality of methionine metabolism (HP:0010901) | 2.88521082 |
| 63 | Chest pain (HP:0100749) | 2.88399141 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.87412091 |
| 65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.85537607 |
| 66 | Esophageal varix (HP:0002040) | 2.76988493 |
| 67 | Episodic fever (HP:0001954) | 2.75708103 |
| 68 | Spastic diplegia (HP:0001264) | 2.75603006 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.74995276 |
| 70 | Hemoptysis (HP:0002105) | 2.74295351 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.70887779 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.70303579 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.67952128 |
| 74 | Arterial thrombosis (HP:0004420) | 2.67094870 |
| 75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.64719959 |
| 76 | Recurrent viral infections (HP:0004429) | 2.64523881 |
| 77 | Glomerulonephritis (HP:0000099) | 2.58026449 |
| 78 | Osteomyelitis (HP:0002754) | 2.57566797 |
| 79 | Epistaxis (HP:0000421) | 2.55212892 |
| 80 | Pulmonary embolism (HP:0002204) | 2.52846148 |
| 81 | Anorexia (HP:0002039) | 2.51856952 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 2.48875183 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.48875183 |
| 84 | Colitis (HP:0002583) | 2.47697293 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 2.47498064 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 2.44163054 |
| 87 | Abnormality of the peritoneum (HP:0002585) | 2.42394663 |
| 88 | Petechiae (HP:0000967) | 2.41422086 |
| 89 | Steatorrhea (HP:0002570) | 2.41189159 |
| 90 | Peritonitis (HP:0002586) | 2.39797316 |
| 91 | Skin nodule (HP:0200036) | 2.38648676 |
| 92 | T lymphocytopenia (HP:0005403) | 2.38031917 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.37370195 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37370195 |
| 95 | Ketoacidosis (HP:0001993) | 2.36329684 |
| 96 | Purpura (HP:0000979) | 2.35932221 |
| 97 | Gout (HP:0001997) | 2.35571108 |
| 98 | Eczematoid dermatitis (HP:0000976) | 2.34274379 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.32629044 |
| 100 | Leukocytosis (HP:0001974) | 2.32538261 |
| 101 | Hyperbilirubinemia (HP:0002904) | 2.31196130 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.29137567 |
| 103 | Increased IgM level (HP:0003496) | 2.28692942 |
| 104 | Nausea (HP:0002018) | 2.28451523 |
| 105 | Vascular calcification (HP:0004934) | 2.28319665 |
| 106 | Pustule (HP:0200039) | 2.27339262 |
| 107 | Malnutrition (HP:0004395) | 2.26514488 |
| 108 | Amyloidosis (HP:0011034) | 2.26143885 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25822241 |
| 110 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25822241 |
| 111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25822241 |
| 112 | Abnormality of T cell number (HP:0011839) | 2.25586986 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24462302 |
| 114 | Loss of speech (HP:0002371) | 2.23519988 |
| 115 | Hypertriglyceridemia (HP:0002155) | 2.23362430 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22323324 |
| 117 | Pancreatitis (HP:0001733) | 2.21829925 |
| 118 | Sepsis (HP:0100806) | 2.21325913 |
| 119 | Increased cerebral lipofuscin (HP:0011813) | 2.18266751 |
| 120 | Cardiovascular calcification (HP:0011915) | 2.18071887 |
| 121 | Nephritis (HP:0000123) | 2.17083570 |
| 122 | Gingival bleeding (HP:0000225) | 2.16499865 |
| 123 | Vacuolated lymphocytes (HP:0001922) | 2.16406961 |
| 124 | Hepatosplenomegaly (HP:0001433) | 2.16182628 |
| 125 | Increased serum ferritin (HP:0003281) | 2.15631533 |
| 126 | Delayed CNS myelination (HP:0002188) | 2.14508990 |
| 127 | Microcytic anemia (HP:0001935) | 2.14162319 |
| 128 | Granulocytopenia (HP:0001913) | 2.13578135 |
| 129 | Hemorrhage of the eye (HP:0011885) | 2.12220682 |
| 130 | Abnormality of the pleura (HP:0002103) | 2.10991392 |
| 131 | Metabolic acidosis (HP:0001942) | 2.10601563 |
| 132 | Gangrene (HP:0100758) | 2.07678840 |
| 133 | Slow saccadic eye movements (HP:0000514) | 2.07372367 |
| 134 | Glomerulopathy (HP:0100820) | 2.06960707 |
| 135 | Abnormality of T cells (HP:0002843) | 2.06717763 |
| 136 | Skin ulcer (HP:0200042) | 2.06460641 |
| 137 | Lymphopenia (HP:0001888) | 2.06242518 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 2.05828522 |
| 139 | Abnormality of the endocardium (HP:0004306) | 2.02702275 |
| 140 | Recurrent bacterial skin infections (HP:0005406) | 2.02438623 |
| 141 | Panhypogammaglobulinemia (HP:0003139) | 2.02224769 |
| 142 | Acne (HP:0001061) | 2.01401086 |
| 143 | Premature loss of primary teeth (HP:0006323) | 1.99738072 |
| 144 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99673716 |
| 145 | Polycythemia (HP:0001901) | 1.99371774 |
| 146 | Axonal loss (HP:0003447) | 1.99253427 |
| 147 | Metaphyseal cupping (HP:0003021) | 1.98417561 |
| 148 | Mitral stenosis (HP:0001718) | 1.98124469 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98050931 |
| 150 | Gastrointestinal stroma tumor (HP:0100723) | 1.97858516 |
| 151 | Lethargy (HP:0001254) | 1.97025123 |
| 152 | Viral hepatitis (HP:0006562) | 1.96414100 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.95814818 |
| 154 | Thrombophlebitis (HP:0004418) | 1.95434275 |
| 155 | Increased mean platelet volume (HP:0011877) | 1.94367752 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88978472 |
| 157 | Recurrent pneumonia (HP:0006532) | 1.88882194 |
| 158 | Irritability (HP:0000737) | 1.88813091 |
| 159 | Acute hepatic failure (HP:0006554) | 1.87129349 |
| 160 | Late onset (HP:0003584) | 1.86295824 |
| 161 | Subacute progressive viral hepatitis (HP:0006572) | 1.84751949 |
| 162 | Nasal polyposis (HP:0100582) | 1.84371233 |
| 163 | Dysostosis multiplex (HP:0000943) | 1.83568629 |
| 164 | Abnormal platelet volume (HP:0011876) | 1.82961031 |
| 165 | Multiple enchondromatosis (HP:0005701) | 1.82902920 |
| 166 | Abnormality of the pericardium (HP:0001697) | 1.82491631 |
| 167 | Agammaglobulinemia (HP:0004432) | 1.82444156 |
| 168 | Interstitial pulmonary disease (HP:0006530) | 1.82156558 |
| 169 | Abnormality of macrophages (HP:0004311) | 1.81609787 |
| 170 | Spontaneous abortion (HP:0005268) | 1.81076570 |
| 171 | Menorrhagia (HP:0000132) | 1.80849344 |
| 172 | Urticaria (HP:0001025) | 1.80207274 |
| 173 | Autoimmune thrombocytopenia (HP:0001973) | 1.78442051 |
| 174 | Neonatal onset (HP:0003623) | 1.77511109 |
| 175 | Cholelithiasis (HP:0001081) | 1.76055763 |
| 176 | Opisthotonus (HP:0002179) | 1.74895499 |
| 177 | Sensorimotor neuropathy (HP:0007141) | 1.74779909 |
| 178 | Abnormality of the Achilles tendon (HP:0005109) | 1.73736582 |
| 179 | Vomiting (HP:0002013) | 1.72173222 |
| 180 | Recurrent abscess formation (HP:0002722) | 1.70920619 |
| 181 | Abnormal gallbladder morphology (HP:0012437) | 1.69794002 |
| 182 | Proximal tubulopathy (HP:0000114) | 1.68574226 |
| 183 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68361356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.62386473 |
| 2 | ERN1 | 4.44986075 |
| 3 | TRIB3 | 4.23300740 |
| 4 | BCKDK | 3.86481380 |
| 5 | PKN2 | 3.10418929 |
| 6 | SIK1 | 2.84246277 |
| 7 | PRPF4B | 2.74909038 |
| 8 | FGFR4 | 2.69026079 |
| 9 | TYK2 | 2.17071413 |
| 10 | FES | 2.08962773 |
| 11 | TNK2 | 1.99185908 |
| 12 | PTK6 | 1.85272981 |
| 13 | EPHB1 | 1.82952687 |
| 14 | TBK1 | 1.76542772 |
| 15 | MAP2K3 | 1.69277953 |
| 16 | FLT3 | 1.65812872 |
| 17 | SMG1 | 1.61562136 |
| 18 | TESK2 | 1.59653753 |
| 19 | LRRK2 | 1.59093722 |
| 20 | EEF2K | 1.58539453 |
| 21 | STK10 | 1.57243378 |
| 22 | EPHA2 | 1.56805162 |
| 23 | KDR | 1.54686962 |
| 24 | TAOK3 | 1.48195189 |
| 25 | MAP4K1 | 1.44930414 |
| 26 | MAP3K13 | 1.44239120 |
| 27 | MAP3K3 | 1.41097983 |
| 28 | MST1R | 1.40930360 |
| 29 | RIPK1 | 1.39203428 |
| 30 | CSK | 1.38759675 |
| 31 | MAP3K1 | 1.37121506 |
| 32 | SYK | 1.33343879 |
| 33 | CAMK1D | 1.32761405 |
| 34 | NEK9 | 1.32579494 |
| 35 | IRAK3 | 1.31420756 |
| 36 | MAP3K10 | 1.27509371 |
| 37 | MAP3K14 | 1.26213256 |
| 38 | BLK | 1.23402164 |
| 39 | GRK6 | 1.21445860 |
| 40 | TTN | 1.19109799 |
| 41 | LYN | 1.17423547 |
| 42 | MARK2 | 1.14776206 |
| 43 | LATS1 | 1.14144644 |
| 44 | TGFBR2 | 1.12964664 |
| 45 | RPS6KA4 | 1.12950878 |
| 46 | JAK3 | 1.12949698 |
| 47 | YES1 | 1.11492554 |
| 48 | PAK4 | 1.09717408 |
| 49 | ABL2 | 1.08904994 |
| 50 | NME2 | 1.08328519 |
| 51 | MAPK11 | 1.07779077 |
| 52 | MAP3K11 | 1.07183893 |
| 53 | PRKD2 | 1.06467320 |
| 54 | SIK3 | 1.04290118 |
| 55 | ERBB4 | 1.03536350 |
| 56 | TXK | 1.03294539 |
| 57 | ZAP70 | 1.03215636 |
| 58 | CDK6 | 1.03012973 |
| 59 | JAK1 | 1.01017074 |
| 60 | MAP3K8 | 1.00958387 |
| 61 | IRAK2 | 0.98666733 |
| 62 | JAK2 | 0.96982193 |
| 63 | MAP3K6 | 0.95733809 |
| 64 | LCK | 0.94846043 |
| 65 | MET | 0.91119975 |
| 66 | PTK2 | 0.90832793 |
| 67 | IRAK1 | 0.90511811 |
| 68 | BMX | 0.90151680 |
| 69 | PDK1 | 0.88304502 |
| 70 | PDGFRA | 0.86448682 |
| 71 | TESK1 | 0.85302719 |
| 72 | CDC42BPA | 0.83938674 |
| 73 | CDK4 | 0.83136795 |
| 74 | CSF1R | 0.82474397 |
| 75 | IKBKE | 0.78829576 |
| 76 | MAP3K2 | 0.78123531 |
| 77 | PIK3CG | 0.77334565 |
| 78 | MARK3 | 0.76557430 |
| 79 | IRAK4 | 0.76495554 |
| 80 | SIK2 | 0.73962654 |
| 81 | BTK | 0.70675173 |
| 82 | NEK2 | 0.69612912 |
| 83 | CDK12 | 0.68416223 |
| 84 | KIT | 0.68355133 |
| 85 | PIM2 | 0.68200677 |
| 86 | STK3 | 0.65242583 |
| 87 | MAP2K2 | 0.64112189 |
| 88 | PIM1 | 0.62249847 |
| 89 | BMPR2 | 0.62198304 |
| 90 | FRK | 0.61685226 |
| 91 | MAP3K7 | 0.61463296 |
| 92 | IKBKB | 0.61092087 |
| 93 | FYN | 0.61072228 |
| 94 | ICK | 0.60954545 |
| 95 | PDK4 | 0.60009841 |
| 96 | PDK3 | 0.60009841 |
| 97 | MTOR | 0.60009349 |
| 98 | MAPK12 | 0.59622262 |
| 99 | PRKAA2 | 0.57064296 |
| 100 | HIPK2 | 0.57059942 |
| 101 | RPS6KL1 | 0.55500334 |
| 102 | RPS6KC1 | 0.55500334 |
| 103 | DYRK1B | 0.55303657 |
| 104 | HCK | 0.55236684 |
| 105 | FGR | 0.54872138 |
| 106 | FGFR3 | 0.54184207 |
| 107 | GSK3A | 0.54177547 |
| 108 | RET | 0.54043603 |
| 109 | MAP2K4 | 0.53379526 |
| 110 | PAK2 | 0.53288746 |
| 111 | SCYL2 | 0.52940327 |
| 112 | NEK1 | 0.52937542 |
| 113 | MAP2K1 | 0.52899631 |
| 114 | MAPKAPK3 | 0.51106047 |
| 115 | RAF1 | 0.50207391 |
| 116 | TAOK2 | 0.50089907 |
| 117 | SGK3 | 0.50038639 |
| 118 | MAPK4 | 0.48845419 |
| 119 | TAOK1 | 0.48442918 |
| 120 | TGFBR1 | 0.47041259 |
| 121 | PDPK1 | 0.46775150 |
| 122 | KSR2 | 0.46704963 |
| 123 | TEC | 0.46535917 |
| 124 | CHUK | 0.45489813 |
| 125 | EGFR | 0.44624090 |
| 126 | CDK19 | 0.44314660 |
| 127 | ITK | 0.44295365 |
| 128 | EIF2AK1 | 0.43698162 |
| 129 | MAPK7 | 0.43669289 |
| 130 | STK38 | 0.43281980 |
| 131 | PRKG2 | 0.42453829 |
| 132 | RPS6KA6 | 0.42274942 |
| 133 | KSR1 | 0.41741844 |
| 134 | STK11 | 0.41061408 |
| 135 | EPHA3 | 0.41054734 |
| 136 | FGFR1 | 0.40394392 |
| 137 | MAPKAPK2 | 0.40179883 |
| 138 | ABL1 | 0.39901722 |
| 139 | MAP3K5 | 0.39148979 |
| 140 | PDK2 | 0.39082906 |
| 141 | RPS6KB2 | 0.38519279 |
| 142 | MATK | 0.38394810 |
| 143 | CAMK1G | 0.38233429 |
| 144 | PTK2B | 0.37640894 |
| 145 | ACVR1B | 0.37544107 |
| 146 | MAP2K6 | 0.37032416 |
| 147 | CAMKK1 | 0.36631234 |
| 148 | RPS6KA2 | 0.36464718 |
| 149 | MOS | 0.36112096 |
| 150 | BUB1 | 0.35699253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58635291 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38319552 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10185644 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62525012 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59099792 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58658336 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58287098 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45254653 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40297008 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39009568 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31248608 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31053376 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29985474 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29692430 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19934398 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.18771117 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12596663 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09861319 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02818827 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01203289 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01141580 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.99172247 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.97635986 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93990588 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.89432918 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84901764 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83919401 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.74515583 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.72090408 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71847437 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69315741 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66883941 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65774324 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65075126 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64871224 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62986262 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62899453 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59712290 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59520734 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.58269924 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56167456 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52349549 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45444700 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45145437 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.44995616 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44310106 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43059442 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41535605 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40644706 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40418524 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39980281 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.39768809 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38775117 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38757735 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37519855 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36291183 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33528758 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32510235 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31668517 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31344105 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25122792 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24722198 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24199186 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23878846 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23453470 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 1.23253386 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21215665 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20151425 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18333170 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17741954 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 1.17549199 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16116943 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12480115 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12389708 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05552982 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04551710 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04031562 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 1.03921515 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03893020 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 1.03419032 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03224736 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 1.02716616 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01088371 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00302344 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00049490 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98644080 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97068532 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.95298823 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95078180 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95062209 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94867325 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94407752 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92837544 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92376133 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91885321 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91678370 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90542421 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89896052 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89574805 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87883698 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.86607413 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85446869 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.83122578 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79114283 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75911215 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75656387 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.74701069 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74413711 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71562317 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70579706 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70145775 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67956112 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66635687 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65989487 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64756769 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64716988 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63539671 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63219601 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62367043 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62191546 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60855890 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60737096 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60219281 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59922055 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57894146 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56371760 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55581584 |
| 128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54267241 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.53081257 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51287523 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51091773 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51011403 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.49912785 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49330111 |
| 135 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48928595 |
| 136 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48400377 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.47359076 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46596515 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45537403 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.44409058 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44214263 |
| 142 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42886605 |
| 143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42643123 |
| 144 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41008507 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39799927 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35891228 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.35830129 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32962793 |
| 149 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32502554 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.31126332 |
| 151 | Prion diseases_Homo sapiens_hsa05020 | 0.28849892 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25876498 |
| 153 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24037105 |
| 154 | Malaria_Homo sapiens_hsa05144 | 0.23454586 |
| 155 | Bladder cancer_Homo sapiens_hsa05219 | 0.23138923 |
| 156 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21915396 |
| 157 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20403527 |
| 158 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19375100 |
| 159 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.18164886 |
| 160 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15394504 |
| 161 | Amoebiasis_Homo sapiens_hsa05146 | 0.15384443 |
| 162 | Hepatitis C_Homo sapiens_hsa05160 | 0.14635445 |
| 163 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.12615432 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12488931 |
| 165 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.12487955 |
| 166 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12193244 |
| 167 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10995241 |
| 168 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10882446 |
| 169 | Apoptosis_Homo sapiens_hsa04210 | 0.09314508 |
| 170 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.09060808 |
| 171 | Tuberculosis_Homo sapiens_hsa05152 | 0.08934619 |
| 172 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08541071 |
| 173 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07800567 |
| 174 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.07682782 |

